Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 31, 2012. The report details a share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,850,000 Ordinary Shares of 25 pence each.
- Purchase Date: May 31, 2012.
- Price Range: Highest price paid was 1,431.5 pence per share; lowest price paid was 1,412.0 pence per share.
- Treasury Holdings (Settled): 446,932,927 shares (8.18% of total issued share capital).
- Treasury Holdings (Including Unsettled): 452,457,927 shares (9.02% of current total voting rights).
- Shares in Issue (Excluding Treasury): 5,017,930,259 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 1,850,000 shares on May 31, 2012. This transaction increased the proportion of shares held in Treasury from the prior level to 8.18% of issued capital (9.02% of voting rights including unsettled shares).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities. The document notes compliance with the Financial Services Authority's Disclosure and Transparency Rules regarding shareholder notification thresholds.
Investor Verification Checklist
- Verify the total number of shares in issue (5,017,930,259) for calculating ownership percentages under Disclosure and Transparency Rules.
- Confirm the settlement status of the 1,850,000 shares purchased on May 31, 2012, to reconcile the difference between settled and total treasury holdings.
- Review the Annual General Meeting minutes from May 3, 2012, to confirm the scope of the share repurchase authority utilized.